A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions
2014 · Genome biology · 38 citations
https://doi.org/10.1186/gb-2014-15-5-r71
S
Shirley Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
23.6K
Citations
37
h-index
48
i10-index
Shirley Zhu is an academic researcher from McGill University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics. The author has an h-index of 37, co-authored 84 publications.
ORCID: 0009-0005-8492-7915Papers by this author
worksThe microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling
2022 · Science Advances · 25 citations
https://doi.org/10.1126/sciadv.abh2445
Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target
2011 · The Journal of Pathology · 21 citations
https://doi.org/10.1002/path.2951
Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer
2013 · Breast Cancer Research · 14 citations
https://doi.org/10.1186/bcr3586
Transcriptome and genome evolution during HER2-amplified breast neoplasia
2021 · Breast Cancer Research · 5 citations
https://doi.org/10.1186/s13058-021-01451-6
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
2023 · Cancer Cell · 3 citations
https://doi.org/10.1016/j.ccell.2023.06.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat